State Street
KYMR icon

State Street’s Kymera Therapeutics KYMR Stock Holding History

State Street’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199M Buy
2,389,767
+179,930
+8% +$14.2M 0.01% 934
2025
Q4 		$172M Buy
2,209,837
+190,383
+9% +$12.9M 0.01% 1030
2025
Q3 		$114M Buy
2,019,454
+465,023
+30% +$21M ﹤0.01% 1258
2025
Q2 		$67.8M Sell
1,554,431
-206,276
-12% -$7.1M ﹤0.01% 1522
2025
Q1 		$48.2M Buy
1,760,707
+71,918
+4% +$2.62M ﹤0.01% 1665
2024
Q4 		$67.9M Sell
1,688,789
-39,355
-2% -$1.78M ﹤0.01% 1559
2024
Q3 		$81.8M Sell
1,728,144
-182,547
-10% -$8.06M ﹤0.01% 1448
2024
Q2 		$57M Sell
1,910,691
-761,827
-29% -$26.4M ﹤0.01% 1606
2024
Q1 		$107M Buy
2,672,518
+778,239
+41% +$27.8M ﹤0.01% 1265
2023
Q4 		$48.2M Sell
1,894,279
-91,607
-5% -$1.64M ﹤0.01% 1721
2023
Q3 		$27.6M Sell
1,985,886
-634,423
-24% -$12.8M ﹤0.01% 1978
2023
Q2 		$60.2M Sell
2,620,309
-106,516
-4% -$3.05M ﹤0.01% 1550
2023
Q1 		$80.8M Sell
2,726,825
-119,396
-4% -$3.85M ﹤0.01% 1326
2022
Q4 		$71M Buy
2,846,221
+160,817
+6% +$4.29M ﹤0.01% 1404
2022
Q3 		$58.5M Sell
2,685,404
-829,034
-24% -$21.9M ﹤0.01% 1492
2022
Q2 		$69.2M Buy
3,514,438
+1,419,877
+68% +$33.2M ﹤0.01% 1419
2022
Q1 		$88.6M Buy
2,094,561
+452,799
+28% +$19.1M ﹤0.01% 1379
2021
Q4 		$104M Buy
1,641,762
+201,986
+14% +$11.8M ﹤0.01% 1267
2021
Q3 		$84.6M Buy
1,439,776
+103,130
+8% +$5.98M ﹤0.01% 1409
2021
Q2 		$64.8M Buy
1,336,646
+399,731
+43% +$17.4M ﹤0.01% 1656
2021
Q1 		$36.4M Buy
936,915
+776,370
+484% +$46.7M ﹤0.01% 1971
2020
Q4 		$9.95M Buy
+160,545
New +$7.83M ﹤0.01% 2631

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return